Effect of transurethral holmium laser resection of bladder tumor treating superficial bladder tumor
YAN Bin-yuan1 LIU Hao2 WEN Zhi-qiang1 WU Tao1
1.Department of Urology,Shenzhen Hospital of Southern Medical University in Guangdong Province,Shenzhen 518100, China;
2.Department of Urology,Sun Yat-sen Memorial Hospital of Sun Yat-sen University in Guangdong Province, Guangzhou 510120,China
Abstract：ObjectiveTo investigate the clinical efficacy and safety of transurethral holmium laser resection of bladder tumor and transurethral resection of bladder tumor treating superficial bladder tumor.Methods196 patients with superficial bladder tumor who underwent surgical treatment in Shenzhen Hospital of Southern Medical University from February 2014 to February 2016 were selected and they were divided into the two groups according to the operation mode,96 cases were treated with transurethral resection of bladder tumor(TURBT group),and 100 cases were treated with transurethral holmium laser resection of bladder tumor(HOLRBT group).The operative time,hospitalization time,the blood loss during operation,bladder irrigation time,catheter indwelling time,complication and tumor recurrence were compared between the two groups.ResultsTwo groups of patients with operation time and hospitalization time were no significant difference(P＞0.05),the HOLRBT group of patients in the amount of blood loss during operation was significantly less than the TURBT group(P＜0.05),bladder irrigation time and catheter indwelling time were significantly shorter than the TURBT group (P＜0.05).The amount of blood loss during operation[(26.3±4.2)ml]in patients of the HOLRBT group was significantly less than the TURBT group[(32.2±5.2)ml](P＜0.05),bladder irrigation time[(25.2±7.4)min)]and catheter indwelling time[(21.5± 5.8)h)]were significantly shorter than those of the TURBT group[(32.2±6.4)min,(34.3±8.2)h](P＜0.05).The incidence of complication in the HOLRBT group(1.0%)was significantly less than that in the TURBT group(18.8%)(P＜0.05).The recurrence rate of the HOLRBT group(12.0%)was significantly lower than that in the TURBT group(22.9%)(P＜0.05).ConclusionThe effect of HOLRBT treating superficial bladder tumor is significant with less damage,less complications,lower recurrence rate,and it is worthy of wide promotion and application in clinic.
Siegel R，Miller K，Jemal A.Cancer statistics，2017[J].CA Cancer J Clin，2017，67（1）：7-30.
[2]
Weir H，Thompson T，Soman A，et al.The past，present，and future of cancer incidence in the United States：1975 through 2020[J].Cancer，2015，121（11）：1827-1837.
京公网安备 11010502046607号